Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Ingrid A. Beck"'
Autor:
Ingrid A. Beck, Ceejay L. Boyce, Marley D. Bishop, Yen L. Vu, Amanda Fung, Sheila Styrchak, Nuttada Panpradist, Barry R. Lutz, Lisa M. Frenkel
Publikováno v:
Viruses, Vol 16, Iss 7, p 1162 (2024)
The WHO currently recommends dolutegravir (DTG)-based ART for persons living with HIV infection in resource-limited-settings (RLS). To expand access to testing for HIV drug resistance (DR) to DTG in RLS, we developed probes for use in the oligonucleo
Externí odkaz:
https://doaj.org/article/5eae2802cfbd4e7381fdb8a745ba669d
Autor:
Ingrid A. Beck, Sheila Styrchak, Leslie Miller, Fred Mast, Vladimir Vigdorovich, Winnie Yeung, Daisy Ko, Alyssa Oldroyd, Samantha Hardy, Song Li, John Houck, Yonghou Jiang, Nicholas Dambrauskas, Catherine Darcey, Andrew Raappana, William Selman, D. Noah Sather, John D. Aitchison, Whitney E. Harrington, Lisa M. Frenkel
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT Biomedical personnel can become contaminated with nonhazardous reagents used in the laboratory. We describe molecular studies performed on nasal secretions collected longitudinally from asymptomatic laboratory coworkers to determine if they
Externí odkaz:
https://doaj.org/article/cf5e3aaaf69246148f1a08716589f2ef
Autor:
Justin D. Vrana, Nuttada Panpradist, Nikki Higa, Daisy Ko, Parker Ruth, Ruth Kanthula, James J. Lai, Yaoyu Yang, Samar R. Sakr, Bhavna Chohan, Michael H. Chung, Lisa M. Frenkel, Barry R. Lutz, Eric Klavins, Ingrid A. Beck
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 2 (2022)
Usability is an overlooked aspect of implementing lab-based assays, particularly novel assays in low-resource-settings. Esoteric instructions can lead to irreproducible test results and patient harm. To address these issues, we developed a software a
Externí odkaz:
https://doaj.org/article/d5a5aee58a1442dd88067bc1b002b298
Autor:
Whitney E. Harrington, Winnie Yeung, Ingrid A. Beck, Fred D. Mast, John Houck, Sheila Styrchak, Leslie R. Miller, Song Li, Micaela Haglund, Yonghou Jiang, Blair Armistead, Jackson Wallner, Tina Nguyen, Daisy Ko, Samantha Hardy, Alyssa Oldroyd, Ana Gervassi, John D. Aitchison, Lisa M. Frenkel
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Background Asymptomatic and pre-symptomatic SARS-CoV-2 infections may contribute to ongoing community transmission, however, the benefit of routine screening of asymptomatic individuals in low-risk populations is unclear. Methods To identify SARS-CoV
Externí odkaz:
https://doaj.org/article/eef1ebf3b2da434aa54c155bced8b70e
Autor:
Ceejay L. Boyce, Ingrid A. Beck, Sheila M. Styrchak, Samantha R. Hardy, Jackson J. Wallner, Ross S. Milne, R. Leavitt Morrison, David E. Shapiro, Esaú C. João, Mark H. Mirochnick, Lisa M. Frenkel
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Objective To assess in ART-naïve pregnant women randomized to efavirenz- versus raltegravir-based ART (IMPAACT P1081) whether pretreatment drug resistance (PDR) with minority frequency variants (Design A case-control study design compared PDR minori
Externí odkaz:
https://doaj.org/article/6414adc493424b66ae36a468a952de97
Autor:
Nuttada Panpradist, Ingrid A. Beck, Justin Vrana, Nikki Higa, David McIntyre, Parker S. Ruth, Isaac So, Enos C. Kline, Ruth Kanthula, Annie Wong-On-Wing, Jonathan Lim, Daisy Ko, Ross Milne, Theresa Rossouw, Ute D. Feucht, Michael Chung, Gonzague Jourdain, Nicole Ngo-Giang-Huong, Laddawan Laomanit, Jaime Soria, James Lai, Eric D. Klavins, Lisa M. Frenkel, Barry R. Lutz
Publikováno v:
EBioMedicine, Vol 50, Iss , Pp 34-44 (2019)
Background: HIV drug resistance (HIVDR) testing can assist clinicians in selecting treatments. However, high complexity and cost of genotyping assays limit routine testing in settings where HIVDR prevalence has reached high levels. Methods: The oligo
Externí odkaz:
https://doaj.org/article/1499a6fb9e9548099493be5626fecefe
Autor:
Nuttada Panpradist, Qin Wang, Parker S. Ruth, Jack H. Kotnik, Amy K. Oreskovic, Abraham Miller, Samuel W.A. Stewart, Justin Vrana, Peter D. Han, Ingrid A. Beck, Lea M. Starita, Lisa M. Frenkel, Barry R. Lutz
Publikováno v:
EBioMedicine, Vol 66, Iss , Pp 103296- (2021)
Externí odkaz:
https://doaj.org/article/193ecbcc82f94824b17341135b7bf121
Autor:
Nuttada Panpradist, Qin Wang, Parker S. Ruth, Jack H. Kotnik, Amy K. Oreskovic, Abraham Miller, Samuel W.A. Stewart, Justin Vrana, Peter D. Han, Ingrid A. Beck, Lea M. Starita, Lisa M. Frenkel, Barry R. Lutz
Publikováno v:
EBioMedicine, Vol 64, Iss , Pp 103236- (2021)
Background: Detection of SARS-CoV-2 infections is important for treatment, isolation of infected and exposed individuals, and contact tracing. RT-qPCR is the “gold-standard” method to sensitively detect SARS-CoV-2 RNA, but most laboratory-develop
Externí odkaz:
https://doaj.org/article/522614cbe40a4a9ebc09f3d2d7ab29e8
Autor:
Horacio A. Duarte, Joseph B. Babigumira, Eva A. Enns, David C. Stauffer, Robert W. Shafer, Ingrid A. Beck, Louis P. Garrison, Jr., Michael H. Chung, Lisa M. Frenkel, Eran Bendavid
Publikováno v:
EClinicalMedicine, Vol 22, Iss , Pp - (2020)
Background: The prevalence of pre-treatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI) agents is increasing in sub-Saharan Africa, which may decrease the effectiveness of efavirenz-based antiretroviral therapy (AR
Externí odkaz:
https://doaj.org/article/48048c2982b14063b4e04fa06aa94da6
Autor:
Ingrid A. Beck, Molly Levine, Christine J. McGrath, Steve Bii, Ross S. Milne, James M. Kingoo, Isaac So, Nina Andersen, Sandra Dross, Robert W. Coombs, James Kiarie, Bhavna Chohan, Samah R. Sakr, Michael H. Chung, Lisa M. Frenkel
Publikováno v:
EClinicalMedicine, Vol 18, Iss , Pp - (2020)
Background: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on tr
Externí odkaz:
https://doaj.org/article/302e55f02ef349b1a0f7c82631578d63